Connective tissue disease: Types, symptoms, and more



acute pid treatment :: Article Creator

Guidelines Covering All Acute Coronary Syndromes Published

The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online today in European Heart Journal. The document covers the management of unstable angina and all types of acute myocardial infarction.

"Time is critical in acute coronary syndromes. When an artery supplying the heart with blood becomes blocked, the quicker we open the artery and restore flow, the less damage occurs to the heart muscle," said Guidelines task force chairperson Professor Robert Byrne of the Mater Private Network and RCSI University of Medicine and Health Sciences, Dublin, Ireland. "Chest pain that lasts for more than 15 minutes and/or recurs within one hour should alert the public to contact the emergency medical services immediately, day or night. Other symptoms include sweating, pain in the shoulder or arm and indigestion."

"Heart disease is the number one cause of death in women and men. A common misconception is that acute coronary syndromes primarily affect men, but women are also at risk and should seek immediate medical help if they have symptoms. Concerningly, several studies have suggested that acute coronary syndromes are underrecognized and undertreated in women but in general, women and men should receive the same treatments. Health care providers must make a concerted effort to ensure that women receive evidence-based care," said Guidelines task force chairperson Professor Borja Ibanez of the National Center for Cardiovascular Research (CNIC) and Fundación Jiménez Díaz University Hospital-CIBERCV, Madrid, Spain.

The heart requires a constant supply of blood to function normally. Blood flow can suddenly reduce or stop when a clot forms in an artery supplying the cardiac muscle, and this is known as acute coronary syndrome. The subtypes of acute coronary syndromes are defined according to the severity of blood flow reduction and its consequences: unstable angina (when no irreversible cardiac muscle damage occurs) and myocardial infarction, also called heart attack (when there is irreversible loss of muscle). Myocardial infarction can be further divided into complete and partial blockages.

Dr. Ibanez said, "One of the key aims of these Guidelines is to highlight that acute coronary syndromes encompass a spectrum of conditions. Some patients have mild symptoms while others become critically ill very quickly. Despite this, much of the management follows the same principles, and this document provides a comprehensive overview."

The guidelines provide detailed advice on treatment, which includes medications such as blood thinners (anticoagulant and antiplatelet therapy). Most patients have a coronary angiogram, which uses X-ray images to see the heart's arteries. When an artery supplying the heart is completely blocked, emergency insertion of a stent via a catheter in the wrist should be performed in a specialist center. Patients in geographically remote areas without a specialist center may instead receive an intravenous clot dissolving drug. When there is no complete blockage, the treatment options are stent insertion, open chest bypass surgery or medical therapy alone.

Long-term management is crucial after an acute coronary syndrome, as patients are at increased risk of a repeat event. Management includes medications such as antiplatelets and aggressive control of cholesterol levels. Patients should attend a supervised cardiac rehabilitation program where they will be encouraged to adopt healthy lifestyle changes, including increasing activity levels, eating a balanced diet, quitting smoking, and taking steps to address psychosocial stress if relevant.

"This will reduce the chances of recurrent events and improve quality of life," said Professor Byrne. "Some patients who experience heart attacks are at risk of developing heart failure because of large damage to the heart muscle and additional medications may be given to reduce this risk."

The guidelines include a new section on the management of acute coronary syndromes in patients with cancer. Those with cancer have an elevated risk of acute coronary syndromes due to shared risk factors such as smoking, type of cancer, and treatment with chemotherapy and radiotherapy. Rates of cancer continue to increase and better treatments mean that more patients with cancer survive, and cardiovascular disease is the leading cause of death.

Those with active cancer are at high risk of bleeding and the guidelines state that this should be taken into account in decisions about management. The guidelines recommend an invasive strategy (e.G., angiography and insertion of stent if needed) in patients with active cancer and an expected survival of at least six months. A temporary interruption of cancer therapy is recommended when it is suspected to be a contributing cause of acute coronary syndrome.

Also new is a section on patient perspectives. The guidelines recommend assessing and adhering to individual patient preferences, needs and beliefs, and ensuring that patient values are used to inform all clinical decisions. The guidelines also advise including patients in decision-making as much as their condition allows and informing them about the risk of adverse events, radiation exposure and alternative options.

More information: Robert A Byrne et al, 2023 ESC Guidelines for the management of acute coronary syndromes, European Heart Journal (2023). DOI: 10.1093/eurheartj/ehad191

Citation: Guidelines covering all acute coronary syndromes published (2023, August 25) retrieved 26 August 2023 from https://medicalxpress.Com/news/2023-08-guidelines-acute-coronary-syndromes-published.Html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.


Treatment For Acute Lymphoblastic Leukaemia

Main treatments for acute lymphoblastic leukaemia

Acute lymphoblastic leukaemia (ALL) is often treatable.

Treatment usually needs to start quickly.

The treatment will depend on:

  • the type of acute lymphoblastic leukaemia you have
  • your age
  • your general health
  • It will usually include steroids and chemotherapy. It may also include targeted medicines, immunotherapy or a stem cell or bone marrow transplant.

    Treatments to prevent and manage symptoms (called supportive treatments) will also be offered.

    The specialist care team looking after you will:

  • explain the treatments, benefits and side effects
  • work with you to create a treatment plan
  • help manage any side effects
  • You'll have regular check-ups during and after any treatments. You may also have tests and scans.

    If you have any symptoms or side effects that you're worried about, talk to your specialists. You do not need to wait for your next check-up.

    Steroids

    Steroid medicine aims to get rid of the leukaemia cells.

    You usually take them for up to a week before you start chemotherapy.

    Information: Find out more Chemotherapy

    Chemotherapy uses medicines to kill cancer cells.

    It's the main treatment for acute lymphoblastic leukaemia.

    You usually have a combination of chemotherapy medicines.

    Information: Find out more Targeted medicines and immunotherapy

    Targeted medicines aim to stop cancer growing.

    Immunotherapy is where medicines are used to help the immune system kill cancer.

    You may have targeted medicines or immunotherapy if:

  • you have certain types of acute lymphoblastic leukaemia
  • the cancer has come back
  • other treatment is not working
  • Information: Find out more Stem cell or bone marrow transplant

    A stem cell or bone marrow transplant replaces damaged blood cells with healthy ones.

    You may have a stem cell or bone marrow transplant if the cancer has come back or it's likely to come back.

    Information: Find out more Supportive treatments

    You may need to have treatment to prevent or control symptoms caused by acute lymphoblastic leukaemia.

    This may include:

  • medicines such as antibiotics to prevent or treat infections
  • blood transfusions
  • medicines called growth factors to help the bone marrow make blood cells
  • vaccines to help protect you from illnesses such as flu and COVID-19
  • Information: Find out more What happens if you've been told your cancer cannot be cured

    Sometimes acute lymphoblastic leukaemia might be very hard to treat, and it may not be possible to cure the cancer.

    If this is the case, the aim of treatment will be to limit the cancer and its symptoms, and help you live longer.

    Finding out the cancer cannot be cured can be very hard news to take in.

    You will be referred to a special team of doctors and nurses called the palliative care team or symptom control team.

    They will work with you to help manage your symptoms and make you feel more comfortable.

    The clinical nurse specialist or palliative care team can also help you and your loved ones get any support you need.

    Information: Find out more

    Pain During Sex Directory

    Sex pain can be caused by sexually transmitted diseases, such as genital herpes. In many cases, a woman can experience painful intercourse if there is not sufficient vaginal lubrication, which may be related to menopause. Other causes include include vaginal infections, intercourse too soon after surgery or childbirth, and pelvic inflammatory disease. Treatment may include estrogen creams or other prescription medications, and if there is no underlying medical cause, therapy. Follow the links below to find WebMD's comprehensive coverage about Sex Pain, possible causes of sex pain, diagnosis of sex pain, treatment of sex pain, and much more.

    Medical Reference View All Features Slideshows & Images Quizzes News Archive View All




    Comments

    Popular posts from this blog